Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Open-Label Multicenter Study of PYLARIFY® PET/CT or PET/MRI in Men With Newly Diagnosed Favorable Intermediate Risk (FIR) Prostate Cancer

NCT06074510 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT06074510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06074510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Open-Label Multicenter Study of PYLARIFY® PET/CT or PET/MRI in Men With Newly Diagnosed Favorable Intermediate Risk (FIR) Prostate Cancer
Lead sponsor
Lantheus Medical Imaging
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 8, 2024
Completion date
September 30, 2026
Enrollment
274 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer